ABCC4 copy number variation is associated with susceptibility to esophageal squamous cell carcinoma

Carcinogenesis

Volumn 35, Issue 9, 2014, Pages 1941-1950

  Sun, Yulin ^a   Shi, Ni ^a   Lu, Haizhen ^a   Zhang, Jinqiang ^a   Ma, Yulong ^b   Qiao, Yuanyuan ^c   Mao, Yonghong ^b   Jia, Kun ^a   Han, Lifen ^b   Liu, Fang ^a   Li, Hongxia ^d   Lin, Zhengwei ^a   Li, Xinmin ^e   Zhao, Xiaohang ^a,c  

^a CANCER HOSPITAL   (China)

^b Cancer Institute of Yangquan City   (China)

^c NAVY GENERAL HOSPITAL   (China)

^d Shanxi Population and Family Planning Science Research Institute   (China)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 13; DNA COPY NUMBER VARIATIONS; ENHANCER ELEMENTS, GENETIC; ESOPHAGEAL NEOPLASMS; FEMALE; GENE DOSAGE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PROGNOSIS; PROTEIN INTERACTION MAPS; RISK;

ABC TRANSPORTER A8; BETA CATENIN; CYCLIC AMP; CYCLOOXYGENASE 2; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; MITOGEN ACTIVATED PROTEIN KINASE; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 4; MYC PROTEIN; PROSTAGLANDIN E RECEPTOR 2; PROTEIN KINASE B;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CELL MEMBRANE; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; COPY NUMBER VARIATION; CORRELATION ANALYSIS; ENHANCER REGION; ENZYME INHIBITION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENE AMPLIFICATION; GENE EXPRESSION; GENE LOCUS; GENE TRANSLOCATION; GENETIC ASSOCIATION; HAN CHINESE; HUMAN; IMMUNOHISTOCHEMISTRY; INTRON; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PROTEIN PHOSPHORYLATION; SIBLING; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84906833011     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgu043     Document Type: Article

References (46)

1. Jemal,A. et al. (2011) Global cancer statistics. Cancer J. Clin., 61, 69-90.
2. Gao,Y. et al. (2009) Family history of cancer and risk for esophageal and gastric cancer in Shanxi, China. BMC Cancer, 9, 269.
3. Liu,M. et al. (2010) Heredity, diet and lifestyle as determining risk factors for the esophageal cancer on Nanao Island in Southern China. Fam. Cancer, 9, 229-238.
4. Li,W. et al. (1998) [Esophageal carcinoma in part of population of Yangquan City]. Zhonghua Yi Xue Za Zhi, 78, 203-206.
5. Zhang,W. et al. (2000) Segregation analysis of esophageal cancer in a moderately high-incidence area of northern China. Am. J. Hum. Genet., 67, 110-119.
6. Cui,R. et al. (2009) Functional variants in ADH1B and ALDH2 coupled with alcohol and smoking synergistically enhance esophageal cancer risk. Gastroenterology, 137, 1768-1775.
7. Tanaka,F. et al. (2010) Strong interaction between the effects of alcohol consumption and smoking on oesophageal squamous cell carcinoma among individuals with ADH1B and/or ALDH2 risk alleles. Gut, 59, 1457-1464.
8. Wang,L.D. et al. (2010) Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54. Nat. Genet., 42, 759-763.
9. Abnet,C.C. et al. (2010) A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat. Genet., 42, 764-767.
10. Wu,C. et al. (2011) Genome-wide association study identifies three new susceptibility loci for esophageal squamous-cell carcinoma in Chinese populations. Nat. Genet., 43, 679-684.
11. Wu,C. et al. (2012) Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactions. Nat. Genet., 44, 1090-1097.
12. Manolio,T.A. et al. (2009) Finding the missing heritability of complex diseases. Nature, 461, 747-753.
13. Redon,R. et al. (2006) Global variation in copy number in the human genome. Nature, 444, 444-454.
14. Girirajan,S. et al. (2011) Human copy number variation and complex genetic disease. Annu. Rev. Genet., 45, 203-226.
15. Diskin,S.J. et al. (2009) Copy number variation at 1q21.1 associated with neuroblastoma. Nature, 459, 987-991.
16. Yoshihara,K. et al. (2011) Germline copy number variations in BRCA1-associated ovarian cancer patients. Genes. Chromosomes Cancer, 50, 167-177.
17. Yu,K.D. et al. (2009) Genetic matters of CYP2D6 in breast cancer: copy number variations and nucleotide polymorphisms. Nat. Rev. Cancer, 9, 842.
18. Day,N. et al. (2007) Unsupervised segmentation of continuous genomic data. Bioinformatics, 23, 1424-1426.
19. Smoot,M.E. et al. (2011) Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics, 27, 431-432.
20. Raychaudhuri,S. et al.; International Schizophrenia Consortium. (2009) Identifying relationships among genomic disease regions: predicting genes at pathogenic SNP associations and rare deletions. PLoS Genet., 5, e1000534.
21. Hao,X.P. et al. (2001) Beta-catenin expression is altered in human colonic aberrant crypt foci. Cancer Res., 61, 8085-8088.
22. Li,C. et al. (2007) Spatiotemporal coupling of cAMP transporter to CFTR chloride channel function in the gut epithelia. Cell, 131, 940-951.
23. Lin,Z.P. et al. (2008) Disruption of cAMP and prostaglandin E2 transport by multidrug resistance protein 4 deficiency alters cAMP-mediated signaling and nociceptive response. Mol. Pharmacol., 73, 243-251.
24. Stranger,B.E. et al. (2007) Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science, 315, 848-853.
25. Laird,N.M. et al. (2006) Family-based designs in the age of large-scale gene-association studies. Nat. Rev. Genet., 7, 385-394.
26. Galvan,A. et al. (2010) Genome-wide association study in discordant sibships identifies multiple inherited susceptibility alleles linked to lung cancer. Carcinogenesis, 31, 462-465.
27. Kuwano,H. et al. (2005) Genetic alterations in esophageal cancer. Surg. Today, 35, 7-18.
28. Pimkhaokham,A. et al. (2000) Nonrandom chromosomal imbalances in esophageal squamous cell carcinoma cell lines: possible involvement of the ATF3 and CENPF genes in the 1q32 amplicon. Jpn. J. Cancer Res., 91, 1126-1133.
29. Du Plessis,L. et al. (1999) Mapping of novel regions of DNA gain and loss by comparative genomic hybridization in esophageal carcinoma in the Black and Colored populations of South Africa. Cancer Res., 59, 1877-1883.
30. Russel,F.G. et al. (2008) Multidrug resistance protein 4 (MRP4/ABCC4): a versatile efflux transporter for drugs and signalling molecules. Trends Pharmacol. Sci., 29, 200-207.
31. Sassi,Y. et al. (2008) Multidrug resistance-associated protein 4 regulates cAMP-dependent signaling pathways and controls human and rat SMC proliferation. J. Clin. Invest., 118, 2747-2757.
32. Hu,N. et al. (2006) Genome-wide loss of heterozygosity and copy number alteration in esophageal squamous cell carcinoma using the Affymetrix GeneChip Mapping 10 K array. BMC Genomics, 7, 299.
33. Smith,B. et al. (2012) Anticancer activity of the cholesterol exporter ABCA1 gene. Cell Rep., 2, 580-590.
34. Sekine,Y. et al. (2010) High-density lipoprotein induces proliferation and migration of human prostate androgen-independent cancer cells by an ABCA1-dependent mechanism. Mol. Cancer Res., 8, 1284-1294.
35. Zhang,P. et al. (1999) Negative cross-talk between hematopoietic regulators: GATA proteins repress PU.1. Proc. Natl Acad. Sci. USA, 96, 8705-8710.
36. Pasello,G. et al. (2009) DNA copy number alterations correlate with survival of esophageal adenocarcinoma patients. Mod. Pathol., 22, 58-65.
37. Norris,M.D. et al. (2005) Expression of multidrug transporter MRP4/ ABCC4 is a marker of poor prognosis in neuroblastoma and confers resistance to irinotecan in vitro. Mol. Cancer Ther., 4, 547-553.
38. Henderson,M.J. et al. (2011) ABCC multidrug transporters in childhood neuroblastoma: clinical and biological effects independent of cytotoxic drug efflux. J. Natl Cancer Inst., 103, 1236-1251.
39. Zhang,Z. et al. (2012) The ABCC4 gene is a promising target for pancreatic cancer therapy. Gene, 491, 194-199.
40. Kleberg,K. et al. (2012) Transporter function and cyclic AMP turnover in normal colonic mucosa from patients with and without colorectal neoplasia. BMC Gastroenterol., 12, 78.
41. Bagnoli,M. et al. (2013) Clinicopathological impact of ABCC1/MRP1 and ABCC4/MRP4 in epithelial ovarian carcinoma. Biomed Res. Int., 2013, 143202.
42. Jedlitschky,G. et al. (2004) The nucleotide transporter MRP4 (ABCC4) is highly expressed in human platelets and present in dense granules, indicating a role in mediator storage. Blood, 104, 3603-3610.
43. Greenhough,A. et al. (2009) The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis, 30, 377-386.
44. Wu,W.K. et al. (2010) Cyclooxygenase-2 in tumorigenesis of gastrointestinal cancers: an update on the molecular mechanisms. Cancer Lett., 295, 7-16.
45. Yu,L. et al. (2009) Prostaglandin E(2) promotes cell proliferation via protein kinase C/extracellular signal regulated kinase pathway-dependent induction of c-Myc expression in human esophageal squamous cell carcinoma cells. Int. J. Cancer, 125, 2540-2546.
46. Shao,J. et al. (2005) Prostaglandin E2 stimulates the beta-catenin/T cell factordependent transcription in colon cancer. J. Biol. Chem., 280, 26565-26572.